IONS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.71%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $13,456,874.62

Ionis Pharmaceuticals Insider Trading History Chart

Ionis Pharmaceuticals Share Price & Price History

^$37.79

▼ -0.27 (-0.71%)

As of 10/10/2024 12:34 PM ET

Days: 30 | 90 | 365

Buffett Dumps $982 Million in BofA Stock—What Does He Know?

From Genesis Gold Group | Ad

Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.

Get your FREE, no-obligation Wealth Protection Guide now

Ionis Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/28/2024	Richard S. Geary	EVP	Sell	320	$49.16	$15,731.20	85,154
8/5/2024	Richard S. Geary	EVP	Sell	2,430	$48.00	$116,640.00	85,508
7/16/2024	Joseph Klein, III	Director	Sell	12,000	$50.00	$600,000.00	16,346
5/3/2024	Joseph Klein, III	Director	Sell	6,000	$42.71	$256,260.00	16,346
4/16/2024	Joseph Baroldi	EVP	Sell	4,006	$41.60	$166,649.60	19,631
2/16/2024	Brett P. Monia	CEO	Sell	387	$44.49	$17,217.63	173,751
2/2/2024	Brett P. Monia	CEO	Sell	23,501	$49.37	$1,160,244.37	174,138
2/2/2024	Elizabeth L. Hougen	CFO	Sell	2,125	$49.54	$105,272.50	92,905
2/2/2024	Eric Swayze	EVP	Sell	1,907	$49.56	$94,510.92	34,324
1/31/2024	Eric Swayze	EVP	Sell	10,773	$52.00	$560,196.00	32,516
1/25/2024	Brett P. Monia	CEO	Sell	2,285	$51.75	$118,248.75	151,851
1/25/2024	Patrick R. O'Neil	EVP	Sell	6,450	$51.75	$333,787.50	46,802
1/17/2024	Brett P. Monia	CEO	Sell	32,059	$50.42	$1,616,414.78	154,136
1/17/2024	Elizabeth L. Hougen	CFO	Sell	8,683	$50.42	$437,796.86	90,890
1/17/2024	Onaiza J. Cadoret-Manier	EVP	Sell	5,564	$50.42	$280,536.88	33,810
1/12/2024	Eugene Schneider	EVP	Sell	8,000	$53.50	$428,000.00	38,170
12/28/2023	B. Lynne Parshall, Esq.	Director	Sell	42,525	$50.19	$2,134,329.75	82,588
12/26/2023	B. Lynne Parshall, Esq.	Director	Sell	25,113	$51.46	$1,292,314.98	82,588
12/26/2023	Patrick R. O'Neil	EVP	Sell	20,825	$51.46	$1,071,654.50	40,355
12/21/2023	Brett P. Monia	CEO	Sell	17,500	$49.29	$862,575.00	118,111
12/20/2023	C. Frank Bennett	EVP	Sell	6,500	$49.64	$322,660.00	65,754
12/14/2023	Brett P. Monia	CEO	Sell	24,000	$49.58	$1,189,920.00	118,111
11/15/2023	Joseph Klein, III	Director	Sell	2,000	$50.00	$100,000.00	16,346
10/17/2023	Eric Swayze	EVP	Sell	52	$47.95	$2,493.40	73
10/12/2023	Brett P. Monia	CEO	Sell	3,770	$46.00	$173,420.00	118,111
9/28/2023	C. Frank Bennett	EVP	Sell	4,460	$46.50	$207,390.00	65,754
9/26/2023	B. Lynne Parshall, Esq.	Director	Sell	10,000	$45.13	$451,300.00	82,588
8/1/2023	Allene M. Diaz	Director	Sell	657	$41.05	$26,969.85	12,676
7/18/2023	Joseph Klein, III	Director	Sell	3,555	$42.00	$149,310.00	20,346
7/7/2023	Brett P. Monia	CEO	Sell	18,650	$42.25	$787,962.50	121,724
5/24/2023	Patrick R. O'Neil	EVP	Sell	1,527	$41.70	$63,675.90	40,355
5/22/2023	Brett P. Monia	CEO	Sell	4,931	$40.14	$197,930.34	140,374
4/18/2023	Brian Birchler	EVP	Sell	672	$36.50	$24,528.00	36,528
2/6/2023	Brett P. Monia	CEO	Sell	24,651	$40.69	$1,003,049.19	145,305
2/6/2023	Elizabeth L. Hougen	CFO	Sell	2,079	$40.59	$84,386.61	75,496
2/6/2023	Eric Swayze	EVP	Sell	1,815	$40.79	$74,033.85	31,941
1/30/2023	Patrick R. O'Neil	EVP	Sell	4,500	$39.42	$177,390.00	44,179
1/18/2023	Brett P. Monia	CEO	Sell	25,066	$39.49	$989,856.34	120,863
1/18/2023	Elizabeth L. Hougen	CFO	Sell	8,280	$39.70	$328,716.00	73,435
1/18/2023	Eric Swayze	EVP	Sell	5,631	$39.74	$223,775.94	30,041
1/17/2023	Joseph Klein, III	Director	Sell	2,000	$40.00	$80,000.00	16,791
9/8/2022	Eric Swayze	EVP	Sell	460	$44.55	$20,493.00	19,892
7/15/2022	Joseph Klein, III	Director	Sell	1,333	$38.24	$50,973.92	18,791
4/21/2022	Eric Swayze	EVP	Sell	378	$44.15	$16,688.70	20,353
4/12/2022	Patrick R. O'Neil	EVP	Sell	6,792	$40.06	$272,087.52	34,536
4/1/2022	Brett P. Monia	CEO	Sell	355	$37.49	$13,308.95	88,662

War on Elon Escalates…

From Porter & Company | Ad

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

SEC Filings (Institutional Ownership Changes) for Ionis Pharmaceuticals (NASDAQ:IONS)

93.86% of Ionis Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ionis Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/8/2024	CWM LLC	1,741	$70K	0.0%	-21.5%	0.001%
10/7/2024	GAMMA Investing LLC	664	$27K	0.0%	+83.9%	0.000%
10/5/2024	Handelsbanken Fonder AB	43,011	$1.72M	0.0%	+26.8%	0.029%
10/3/2024	SG Americas Securities LLC	7,419	$0.30M	0.0%	N/A	0.005%
9/5/2024	Sanctuary Advisors LLC	16,441	$0.78M	0.0%	N/A	0.011%
8/27/2024	Clearbridge Investments LLC	2,160,270	$102.96M	0.1%	-51.6%	1.480%
8/21/2024	Truist Financial Corp	8,003	$0.38M	0.0%	-15.7%	0.005%
8/19/2024	Point72 Asset Management L.P.	137,210	$6.54M	0.0%	-52.1%	0.094%
8/16/2024	Algert Global LLC	75,350	$3.59M	0.1%	+149.2%	0.052%
8/15/2024	Susquehanna Portfolio Strategies LLC	43,028	$2.05M	0.1%	-67.2%	0.029%
8/15/2024	The Manufacturers Life Insurance Company	274,850	$13.10M	0.0%	+12.2%	0.188%
8/15/2024	Millennium Management LLC	128,215	$6.11M	0.0%	-78.0%	0.088%
8/14/2024	Squarepoint Ops LLC	436,818	$20.82M	0.0%	-41.4%	0.299%
8/14/2024	Cubist Systematic Strategies LLC	35,311	$1.68M	0.0%	-87.3%	0.024%
8/14/2024	Point72 DIFC Ltd	4,694	$0.22M	0.0%	-83.5%	0.003%
8/14/2024	Great Point Partners LLC	330,000	$15.73M	3.0%	N/A	0.226%
8/14/2024	Marshall Wace LLP	173,199	$8.26M	0.0%	+1,021.5%	0.119%
8/14/2024	Logos Global Management LP	300,000	$14.30M	1.1%	N/A	0.206%
8/14/2024	Farallon Capital Management LLC	4,800	$0.23M	0.0%	-99.3%	0.003%
8/14/2024	Xponance Inc.	18,115	$0.86M	0.0%	+11.8%	0.012%
8/14/2024	Bank of Montreal Can	220,518	$10.52M	0.0%	-37.5%	0.151%
8/14/2024	DRW Securities LLC	50,956	$2.43M	0.1%	N/A	0.035%
8/14/2024	Itau Unibanco Holding S.A.	767	$37K	0.0%	N/A	0.001%
8/14/2024	ProShare Advisors LLC	9,011	$0.43M	0.0%	-11.8%	0.006%
8/14/2024	Profund Advisors LLC	29,983	$1.43M	0.1%	-5.0%	0.021%
8/13/2024	Ensign Peak Advisors Inc	68,270	$3.25M	0.0%	+28.0%	0.047%
8/13/2024	Granite Investment Partners LLC	114,090	$5.44M	0.2%	-1.8%	0.078%
8/13/2024	Public Employees Retirement Association of Colorado	15,589	$0.74M	0.0%	-5.9%	0.011%
8/12/2024	Hsbc Holdings PLC	5,326	$0.25M	0.0%	N/A	0.004%
8/12/2024	Blair William & Co. IL	25,262	$1.20M	0.0%	-9.3%	0.017%
8/12/2024	Vanguard Personalized Indexing Management LLC	7,624	$0.36M	0.0%	+3.5%	0.005%
8/12/2024	Amalgamated Bank	9,657	$0.46M	0.0%	+4.9%	0.007%
8/12/2024	E Fund Management Co. Ltd.	10,255	$0.49M	0.0%	+4.4%	0.007%
8/9/2024	Renaissance Technologies LLC	249,514	$11.89M	0.0%	+38.8%	0.171%
8/9/2024	Dimensional Fund Advisors LP	88,746	$4.23M	0.0%	-18.8%	0.061%
8/8/2024	Envestnet Asset Management Inc.	77,415	$3.69M	0.0%	-46.6%	0.053%
8/8/2024	State of New Jersey Common Pension Fund D	55,349	$2.64M	0.0%	-32.4%	0.038%
8/8/2024	Nicollet Investment Management Inc.	20,108	$0.96M	0.4%	-2.0%	0.014%
8/6/2024	Quest Partners LLC	1,373	$65K	0.0%	-40.2%	0.001%
8/6/2024	Candriam S.C.A.	948,266	$45.19M	0.3%	+4.0%	0.650%
8/5/2024	Private Advisor Group LLC	46,426	$2.21M	0.0%	-3.2%	0.032%
8/5/2024	Arizona State Retirement System	36,722	$1.75M	0.0%	+3.5%	0.025%
8/5/2024	Victory Capital Management Inc.	17,330	$0.83M	0.0%	-1.7%	0.012%
8/3/2024	TD Asset Management Inc	952,762	$45.41M	0.0%	+6.1%	0.653%
8/2/2024	Archer Investment Corp	600	$29K	0.0%	-29.4%	0.000%
8/1/2024	Rhumbline Advisers	178,089	$8.49M	0.0%	-0.7%	0.122%
8/1/2024	Natixis Advisors LLC	23,404	$1.12M	0.0%	+1.6%	0.016%
8/1/2024	Privium Fund Management B.V.	247,267	$11.16M	2.9%	+8.9%	0.169%
8/1/2024	Lisanti Capital Growth LLC	10,845	$0.52M	0.1%	-61.0%	0.007%
7/31/2024	nVerses Capital LLC	600	$29K	0.0%	N/A	0.000%
7/31/2024	Nicola Wealth Management LTD.	74,000	$3.53M	0.4%	+32.1%	0.051%
7/31/2024	Van ECK Associates Corp	50,264	$2.40M	0.0%	-44.8%	0.034%
7/31/2024	Commonwealth Equity Services LLC	22,669	$1.08M	0.0%	+3.2%	0.016%
7/30/2024	International Assets Investment Management LLC	9,707	$0.46M	0.0%	+27.6%	0.007%
7/29/2024	Peregrine Capital Management LLC	132,024	$6.29M	0.2%	+11.3%	0.090%
7/29/2024	Principal Financial Group Inc.	17,458	$0.83M	0.0%	-41.5%	0.012%
7/26/2024	BLB&B Advisors LLC	153,750	$7.33M	0.4%	+5.2%	0.105%
7/26/2024	Checchi Capital Advisers LLC	4,234	$0.20M	0.0%	N/A	0.003%
7/26/2024	ARK Investment Management LLC	1,361,025	$64.87M	0.6%	-2.8%	0.932%
7/26/2024	Liontrust Investment Partners LLP	59,644	$2.84M	0.0%	-79.3%	0.041%
7/25/2024	Baillie Gifford & Co.	260,254	$12.40M	0.0%	-12.0%	0.178%
7/20/2024	China Universal Asset Management Co. Ltd.	17,150	$0.82M	0.1%	-38.8%	0.012%
7/19/2024	Sumitomo Mitsui Trust Holdings Inc.	199,231	$9.50M	0.0%	-9.5%	0.136%
7/18/2024	Assenagon Asset Management S.A.	24,226	$1.16M	0.0%	-91.1%	0.017%
7/18/2024	Swedbank AB	129,373	$6.17M	0.0%	-9.3%	0.089%
7/12/2024	Mitchell & Pahl Private Wealth LLC	4,540	$0.22M	0.1%	N/A	0.003%
7/9/2024	Mather Group LLC.	911	$39K	0.0%	+35.8%	0.001%
6/4/2024	DekaBank Deutsche Girozentrale	93,807	$4.16M	0.0%	+2.4%	0.064%
5/28/2024	Teachers Retirement System of The State of Kentucky	24,083	$1.04M	0.0%	+70.6%	0.016%
5/24/2024	Farallon Capital Management LLC	734,000	$31.82M	0.1%	-52.8%	0.503%
5/21/2024	Swedbank AB	142,641	$6.18M	0.0%	N/A	0.098%
5/17/2024	Zimmer Partners LP	270,300	$11.72M	0.3%	N/A	0.185%
5/17/2024	Tidal Investments LLC	20,405	$0.89M	0.0%	N/A	0.014%
5/16/2024	California State Teachers Retirement System	131,818	$5.71M	0.0%	-4.8%	0.090%
5/16/2024	Jacobs Levy Equity Management Inc.	571,763	$24.79M	0.1%	+12.2%	0.392%
5/16/2024	Kennedy Capital Management LLC	249,527	$10.82M	0.2%	+9.2%	0.171%
5/16/2024	Paloma Partners Management Co	4,909	$0.21M	0.0%	N/A	0.003%
5/15/2024	Public Employees Retirement System of Ohio	54,493	$2.36M	0.0%	-8.6%	0.037%
5/15/2024	Bellevue Group AG	8,299,514	$359.78M	5.5%	-4.8%	5.686%
5/15/2024	Price T Rowe Associates Inc. MD	3,522,203	$152.69M	0.0%	-17.2%	2.413%
5/14/2024	Advisors Asset Management Inc.	3,178	$0.14M	0.0%	+948.8%	0.002%
5/14/2024	Natixis	1,961	$85K	0.0%	-31.9%	0.001%
5/14/2024	CANADA LIFE ASSURANCE Co	41,880	$1.82M	0.0%	+2.7%	0.029%
5/13/2024	Clearbridge Investments LLC	4,466,191	$193.61M	0.2%	-5.1%	3.060%
5/11/2024	Edgestream Partners L.P.	17,646	$0.77M	0.0%	N/A	0.012%
5/10/2024	Acadian Asset Management LLC	5,891	$0.26M	0.0%	N/A	0.004%
5/10/2024	Vanguard Group Inc.	13,430,456	$582.21M	0.0%	-5.4%	9.215%
5/10/2024	Tocqueville Asset Management L.P.	159,380	$6.91M	0.1%	-0.3%	0.109%
5/9/2024	Blair William & Co. IL	27,838	$1.21M	0.0%	+67.4%	0.019%
5/9/2024	Midwest Professional Planners LTD.	9,716	$0.42M	0.1%	+14.1%	0.007%
5/9/2024	State Board of Administration of Florida Retirement System	155,145	$6.73M	0.0%	+2.7%	0.106%
5/8/2024	Entropy Technologies LP	14,542	$0.63M	0.1%	N/A	0.010%
5/8/2024	Bleakley Financial Group LLC	16,229	$0.70M	0.0%	+32.6%	0.011%
5/8/2024	ProShare Advisors LLC	10,216	$0.44M	0.0%	+11.4%	0.007%
5/7/2024	Susquehanna Fundamental Investments LLC	45,574	$1.98M	0.1%	N/A	0.031%
5/7/2024	Susquehanna Portfolio Strategies LLC	130,986	$5.68M	0.1%	-22.8%	0.090%
5/7/2024	Swiss National Bank	254,900	$11.05M	0.0%	+0.2%	0.175%
5/7/2024	Lisanti Capital Growth LLC	27,835	$1.21M	0.3%	-55.4%	0.019%
5/7/2024	SG Americas Securities LLC	7,582	$0.33M	0.0%	+23.7%	0.005%
5/6/2024	Bard Financial Services Inc.	9,950	$0.43M	0.0%	-29.4%	0.007%

Data available starting January 2016

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was incorporated in 1989 and is based in Carlsbad, California.

Today's Range

Now: $37.79

$37.00

$37.88

50 Day Range

MA: $44.54

$37.80

$51.32

52 Week Range

Now: $37.79

$35.95

$54.44

Volume

280,487 shs

Average Volume

1,327,534 shs

Market Capitalization

$5.52 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.38

Who are the company insiders with the largest holdings of Ionis Pharmaceuticals?: Ionis Pharmaceuticals' top insider investors include:
Brett P Monia (CEO)
Elizabeth L Hougen (CFO)
Richard S Geary (EVP)
B Lynne Parshall (Director)
C Frank Bennett (EVP)
Patrick R O'neil (EVP)
Eugene Schneider (EVP)
Brian Birchler (EVP)
Eric Swayze (EVP)
Onaiza Cadoret-Manier (EVP)
Joseph Klein III (Director)
Joseph Baroldi (EVP)
Allene M Diaz (Director)
Learn More about top insider investors at Ionis Pharmaceuticals.
Who are the major institutional investors of Ionis Pharmaceuticals?: Ionis Pharmaceuticals' top institutional shareholders include:
Handelsbanken Fonder AB — 0.03%
SG Americas Securities LLC — 0.01%
CWM LLC — 0.00%
GAMMA Investing LLC — 0.00%
Learn More about top institutional investors of Ionis Pharmaceuticals stock.
Which institutional investors are selling Ionis Pharmaceuticals stock?: In the last quarter, IONS stock was sold by these institutional investors:
CWM LLC
In the previous year, company insiders that have sold Ionis Pharmaceuticals company stock include:
Brett P Monia (CEO)
Elizabeth L Hougen (CFO)
Richard S Geary (EVP)
B Lynne Parshall (Director)
C Frank Bennett (EVP)
Patrick R O'neil (EVP)
Eugene Schneider (EVP)
Brian Birchler (EVP)
Eric Swayze (EVP)
Onaiza Cadoret-Manier (EVP)
Joseph Klein III (Director)
Learn More investors selling Ionis Pharmaceuticals stock.
Which institutional investors are buying Ionis Pharmaceuticals stock?: During the last quarter, IONS stock was purchased by institutional investors including:
Handelsbanken Fonder AB
SG Americas Securities LLC
GAMMA Investing LLC